A St. Louis startup is pioneering a new approach to gene editing in crops, and the National Science Foundation just gave it a ...

Metagenomi Inc. (NASDAQ: MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced ...

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

CRISPR construct to genetically ablate the GABA transporter GAT3 in the mouse visual cortex, with effects on population-level neuronal activity. This work is important, as it sheds light on how GAT3 ...

Scientists have gene-hacked mice to produce their own Ozempic-like drugs, paving a path for humans to do so themselves one ...

An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific cholesterol-raising conditions.

T cell-based immunotherapy, a form of cancer treatment, harnesses a patient’s own T cells — white blood cells that help fight disease — by modifying or enhancing them to target and destroy cancer ...

The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

When it comes to cutting-edge health technology, Jecizer Biosciences is quickly becoming the name you’ve probably haven’t ...

The global Molecular Biology Enzymes, Kits & Reagents Market is estimated to be valued at USD 25,900.5 million in 2025 and is projected to reach USD 64,187.5 million by 2035, registering a CAGR of 9.5 ...

Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in comparison to traditional statin therapies. This is especially true for ...